Sienna+MR Long-term Uptake
- Conditions
- Breast Cancer Female
- Registration Number
- NCT03243435
- Lead Sponsor
- Kantonsspital Baden
- Brief Summary
In a previous study in 2012/2013 patients were injected a superparamagnetic iron oxide for sentinel lymph node detection. In this follow up study we want to investigate how much of this tracer is still detectable.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 34
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method I) Analysis if the supraparamegnetic Tracer is still detectable 04/2017 Analysis by two expert radiologists
- Secondary Outcome Measures
Name Time Method Analysis to which degree of impairment of Imaging is detected 04/2017 Description as "no impairment", impairment, but Interpretation of Images possible", "impairment, Image Interpretation impossible"
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Kantonsspital Baden
🇨🇭Baden, Aargau, Switzerland
Kantonsspital Baden🇨🇭Baden, Aargau, Switzerland